Grand Pharmaceutical Group (FRA:MX6A) Other Income (Expense) : €103 Mil (TTM As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Grand Pharmaceutical Group Other Income (Expense)?

Grand Pharmaceutical Group's other income expense for the Grand Pharmaceutical Group's pretax income for the six months ended in Dec. 2024 was €38 Mil. Its other income expense for the trailing twelve months (TTM) ended in Dec. 2024 was €103 Mil.

Grand Pharmaceutical Group Other Income (Expense) Historical Data

The historical data trend for Grand Pharmaceutical Group's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Grand Pharmaceutical Group Other Income (Expense) Chart

Grand Pharmaceutical Group Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Income (Expense)

Get a 7-Day Free Trial

42.66

89.57

-5.89

-33.08

104.95

Grand Pharmaceutical Group Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Other Income (Expense)	Get a 7-Day Free Trial															37.43	-11.31	-21.81	64.81	38.01

Grand Pharmaceutical Group Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €103 Mil.

Grand Pharmaceutical Group (FRA:MX6A) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Grand Pharmaceutical Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Grand Pharmaceutical Group Ltd (FRA:MX6A) » Definitions » Other Income (Expense)

Traded in Other Exchanges

00512:Hong Kong MX6A:Germany

Address

99 Queen's Road, Units 3302, 33rd Floor, The Center, Central, Hong Kong, HKG

Website

https://www.grandpharma.cn/en

Grand Pharmaceutical Group Ltd, formerly China Grand Pharmaceutical and Healthcare Holdings Ltd is a drug manufacturer. The company through its subsidiaries manufactures and sells pharmaceutical preparations and medical devices, biotechnology products, nutrition products, specialized pharmaceutical raw materials, and other products. Geographically, it derives a majority of revenue from the PRC and also has a presence in America; Europe; Asia other than the PRC and others.

Grand Pharmaceutical Group Headlines

No Headlines